Global Nifedipine Extended Release Tablets Market Research Report 2026(Status and Outlook)
By inhibiting the calcium channel on the cell membrane, slowing down the inflow of calcium ions, reducing the contractility of the heart and the oxygen consumption of the heart, thereby dilating the coronary arteries, increasing the blood supply to the heart, lowering blood pressure, improving the blood supply to the heart and reducing the burden on the heart. Because it is a sustained-release tablet, the drug is released at a controlled rate, allowing its effects to last for a period of time.
The global Nifedipine Extended Release Tablets market size was estimated at USD 1425.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.15% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nifedipine Extended Release Tablets market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nifedipine Extended Release Tablets market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nifedipine Extended Release Tablets market.
Global Nifedipine Extended Release Tablets Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Valeant Pharmaceuticals
Zydus Pharmaceuticals Inc
Aurobindo Pharma LTD
Pfizer Inc
Sun Pharma Industries LTD
Osmotica Pharmaceuticals
Alkem Laboratories Ltd.
Novast Novast Laboratories, LTD
TWi Pharmaceuticals Inc.
Shyndec Pharmaceutical Co., Ltd
China National Pharmaceutical Industry Co., Ltd
China Resource Pharmaceutical Group Co., Ltd
Anglikang Pharmaceutical Co., Ltd
Warrant Chiral Pharmaceutical Co., Ltd
Tailison Pharmaceutical Co., Ltd
Baheal Medical Inc.
Bocheng Pharmaceutical Co., Ltd
Market Segmentation (by Type)
Original Drug
Generic Drug
Market Segmentation (by Application)
Hospital
Pharmacy
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nifedipine Extended Release Tablets Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nifedipine Extended Release Tablets, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Nifedipine Extended Release Tablets market size was estimated at USD 1425.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.15% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nifedipine Extended Release Tablets market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nifedipine Extended Release Tablets market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nifedipine Extended Release Tablets market.
Global Nifedipine Extended Release Tablets Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Valeant Pharmaceuticals
Zydus Pharmaceuticals Inc
Aurobindo Pharma LTD
Pfizer Inc
Sun Pharma Industries LTD
Osmotica Pharmaceuticals
Alkem Laboratories Ltd.
Novast Novast Laboratories, LTD
TWi Pharmaceuticals Inc.
Shyndec Pharmaceutical Co., Ltd
China National Pharmaceutical Industry Co., Ltd
China Resource Pharmaceutical Group Co., Ltd
Anglikang Pharmaceutical Co., Ltd
Warrant Chiral Pharmaceutical Co., Ltd
Tailison Pharmaceutical Co., Ltd
Baheal Medical Inc.
Bocheng Pharmaceutical Co., Ltd
Market Segmentation (by Type)
Original Drug
Generic Drug
Market Segmentation (by Application)
Hospital
Pharmacy
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nifedipine Extended Release Tablets Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nifedipine Extended Release Tablets Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nifedipine Extended Release Tablets, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nifedipine Extended Release Tablets
1.2 Key Market Segments
1.2.1 Nifedipine Extended Release Tablets Segment by Type
1.2.2 Nifedipine Extended Release Tablets Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nifedipine Extended Release Tablets Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nifedipine Extended Release Tablets Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nifedipine Extended Release Tablets Product Life Cycle
3.3 Global Nifedipine Extended Release Tablets Sales by Manufacturers (2020-2025)
3.4 Global Nifedipine Extended Release Tablets Revenue Market Share by Manufacturers (2020-2025)
3.5 Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nifedipine Extended Release Tablets Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nifedipine Extended Release Tablets Market Competitive Situation and Trends
3.8.1 Nifedipine Extended Release Tablets Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nifedipine Extended Release Tablets Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NIFEDIPINE EXTENDED RELEASE TABLETS INDUSTRY CHAIN ANALYSIS
4.1 Nifedipine Extended Release Tablets Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NIFEDIPINE EXTENDED RELEASE TABLETS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nifedipine Extended Release Tablets Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nifedipine Extended Release Tablets Market
5.7 ESG Ratings of Leading Companies
6 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2025)
6.3 Global Nifedipine Extended Release Tablets Market Size by Type (2020-2025)
6.4 Global Nifedipine Extended Release Tablets Price by Type (2020-2025)
7 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nifedipine Extended Release Tablets Market Sales by Application (2020-2025)
7.3 Global Nifedipine Extended Release Tablets Market Size (M USD) by Application (2020-2025)
7.4 Global Nifedipine Extended Release Tablets Sales Growth Rate by Application (2020-2025)
8 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET SALES BY REGION
8.1 Global Nifedipine Extended Release Tablets Sales by Region
8.1.1 Global Nifedipine Extended Release Tablets Sales by Region
8.1.2 Global Nifedipine Extended Release Tablets Sales Market Share by Region
8.2 Global Nifedipine Extended Release Tablets Market Size by Region
8.2.1 Global Nifedipine Extended Release Tablets Market Size by Region
8.2.2 Global Nifedipine Extended Release Tablets Market Size by Region
8.3 North America
8.3.1 North America Nifedipine Extended Release Tablets Sales by Country
8.3.2 North America Nifedipine Extended Release Tablets Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nifedipine Extended Release Tablets Sales by Country
8.4.2 Europe Nifedipine Extended Release Tablets Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nifedipine Extended Release Tablets Sales by Region
8.5.2 Asia Pacific Nifedipine Extended Release Tablets Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nifedipine Extended Release Tablets Sales by Country
8.6.2 South America Nifedipine Extended Release Tablets Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nifedipine Extended Release Tablets Sales by Region
8.7.2 Middle East and Africa Nifedipine Extended Release Tablets Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET PRODUCTION BY REGION
9.1 Global Production of Nifedipine Extended Release Tablets by Region(2020-2025)
9.2 Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2025)
9.3 Global Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nifedipine Extended Release Tablets Production
9.4.1 North America Nifedipine Extended Release Tablets Production Growth Rate (2020-2025)
9.4.2 North America Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nifedipine Extended Release Tablets Production
9.5.1 Europe Nifedipine Extended Release Tablets Production Growth Rate (2020-2025)
9.5.2 Europe Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nifedipine Extended Release Tablets Production (2020-2025)
9.6.1 Japan Nifedipine Extended Release Tablets Production Growth Rate (2020-2025)
9.6.2 Japan Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nifedipine Extended Release Tablets Production (2020-2025)
9.7.1 China Nifedipine Extended Release Tablets Production Growth Rate (2020-2025)
9.7.2 China Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Valeant Pharmaceuticals
10.1.1 Valeant Pharmaceuticals Basic Information
10.1.2 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Overview
10.1.3 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Market Performance
10.1.4 Valeant Pharmaceuticals Business Overview
10.1.5 Valeant Pharmaceuticals SWOT Analysis
10.1.6 Valeant Pharmaceuticals Recent Developments
10.2 Zydus Pharmaceuticals Inc
10.2.1 Zydus Pharmaceuticals Inc Basic Information
10.2.2 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Overview
10.2.3 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Market Performance
10.2.4 Zydus Pharmaceuticals Inc Business Overview
10.2.5 Zydus Pharmaceuticals Inc SWOT Analysis
10.2.6 Zydus Pharmaceuticals Inc Recent Developments
10.3 Aurobindo Pharma LTD
10.3.1 Aurobindo Pharma LTD Basic Information
10.3.2 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Overview
10.3.3 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Market Performance
10.3.4 Aurobindo Pharma LTD Business Overview
10.3.5 Aurobindo Pharma LTD SWOT Analysis
10.3.6 Aurobindo Pharma LTD Recent Developments
10.4 Pfizer Inc
10.4.1 Pfizer Inc Basic Information
10.4.2 Pfizer Inc Nifedipine Extended Release Tablets Product Overview
10.4.3 Pfizer Inc Nifedipine Extended Release Tablets Product Market Performance
10.4.4 Pfizer Inc Business Overview
10.4.5 Pfizer Inc Recent Developments
10.5 Sun Pharma Industries LTD
10.5.1 Sun Pharma Industries LTD Basic Information
10.5.2 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Overview
10.5.3 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Market Performance
10.5.4 Sun Pharma Industries LTD Business Overview
10.5.5 Sun Pharma Industries LTD Recent Developments
10.6 Osmotica Pharmaceuticals
10.6.1 Osmotica Pharmaceuticals Basic Information
10.6.2 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Overview
10.6.3 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Market Performance
10.6.4 Osmotica Pharmaceuticals Business Overview
10.6.5 Osmotica Pharmaceuticals Recent Developments
10.7 Alkem Laboratories Ltd.
10.7.1 Alkem Laboratories Ltd. Basic Information
10.7.2 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Overview
10.7.3 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Market Performance
10.7.4 Alkem Laboratories Ltd. Business Overview
10.7.5 Alkem Laboratories Ltd. Recent Developments
10.8 Novast Novast Laboratories, LTD
10.8.1 Novast Novast Laboratories, LTD Basic Information
10.8.2 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Overview
10.8.3 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Market Performance
10.8.4 Novast Novast Laboratories, LTD Business Overview
10.8.5 Novast Novast Laboratories, LTD Recent Developments
10.9 TWi Pharmaceuticals Inc.
10.9.1 TWi Pharmaceuticals Inc. Basic Information
10.9.2 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Overview
10.9.3 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Market Performance
10.9.4 TWi Pharmaceuticals Inc. Business Overview
10.9.5 TWi Pharmaceuticals Inc. Recent Developments
10.10 Shyndec Pharmaceutical Co., Ltd
10.10.1 Shyndec Pharmaceutical Co., Ltd Basic Information
10.10.2 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.10.3 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.10.4 Shyndec Pharmaceutical Co., Ltd Business Overview
10.10.5 Shyndec Pharmaceutical Co., Ltd Recent Developments
10.11 China National Pharmaceutical Industry Co., Ltd
10.11.1 China National Pharmaceutical Industry Co., Ltd Basic Information
10.11.2 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.11.3 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.11.4 China National Pharmaceutical Industry Co., Ltd Business Overview
10.11.5 China National Pharmaceutical Industry Co., Ltd Recent Developments
10.12 China Resource Pharmaceutical Group Co., Ltd
10.12.1 China Resource Pharmaceutical Group Co., Ltd Basic Information
10.12.2 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.12.3 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.12.4 China Resource Pharmaceutical Group Co., Ltd Business Overview
10.12.5 China Resource Pharmaceutical Group Co., Ltd Recent Developments
10.13 Anglikang Pharmaceutical Co., Ltd
10.13.1 Anglikang Pharmaceutical Co., Ltd Basic Information
10.13.2 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.13.3 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.13.4 Anglikang Pharmaceutical Co., Ltd Business Overview
10.13.5 Anglikang Pharmaceutical Co., Ltd Recent Developments
10.14 Warrant Chiral Pharmaceutical Co., Ltd
10.14.1 Warrant Chiral Pharmaceutical Co., Ltd Basic Information
10.14.2 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.14.3 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.14.4 Warrant Chiral Pharmaceutical Co., Ltd Business Overview
10.14.5 Warrant Chiral Pharmaceutical Co., Ltd Recent Developments
10.15 Tailison Pharmaceutical Co., Ltd
10.15.1 Tailison Pharmaceutical Co., Ltd Basic Information
10.15.2 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.15.3 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.15.4 Tailison Pharmaceutical Co., Ltd Business Overview
10.15.5 Tailison Pharmaceutical Co., Ltd Recent Developments
10.16 Baheal Medical Inc.
10.16.1 Baheal Medical Inc. Basic Information
10.16.2 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Overview
10.16.3 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Market Performance
10.16.4 Baheal Medical Inc. Business Overview
10.16.5 Baheal Medical Inc. Recent Developments
10.17 Bocheng Pharmaceutical Co., Ltd
10.17.1 Bocheng Pharmaceutical Co., Ltd Basic Information
10.17.2 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.17.3 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.17.4 Bocheng Pharmaceutical Co., Ltd Business Overview
10.17.5 Bocheng Pharmaceutical Co., Ltd Recent Developments
11 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET FORECAST BY REGION
11.1 Global Nifedipine Extended Release Tablets Market Size Forecast
11.2 Global Nifedipine Extended Release Tablets Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nifedipine Extended Release Tablets Market Size Forecast by Country
11.2.3 Asia Pacific Nifedipine Extended Release Tablets Market Size Forecast by Region
11.2.4 South America Nifedipine Extended Release Tablets Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nifedipine Extended Release Tablets by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nifedipine Extended Release Tablets Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nifedipine Extended Release Tablets by Type (2026-2035)
12.1.2 Global Nifedipine Extended Release Tablets Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nifedipine Extended Release Tablets by Type (2026-2035)
12.2 Global Nifedipine Extended Release Tablets Market Forecast by Application (2026-2035)
12.2.1 Global Nifedipine Extended Release Tablets Sales (K MT) Forecast by Application
12.2.2 Global Nifedipine Extended Release Tablets Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nifedipine Extended Release Tablets
1.2 Key Market Segments
1.2.1 Nifedipine Extended Release Tablets Segment by Type
1.2.2 Nifedipine Extended Release Tablets Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nifedipine Extended Release Tablets Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nifedipine Extended Release Tablets Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nifedipine Extended Release Tablets Product Life Cycle
3.3 Global Nifedipine Extended Release Tablets Sales by Manufacturers (2020-2025)
3.4 Global Nifedipine Extended Release Tablets Revenue Market Share by Manufacturers (2020-2025)
3.5 Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nifedipine Extended Release Tablets Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nifedipine Extended Release Tablets Market Competitive Situation and Trends
3.8.1 Nifedipine Extended Release Tablets Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nifedipine Extended Release Tablets Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NIFEDIPINE EXTENDED RELEASE TABLETS INDUSTRY CHAIN ANALYSIS
4.1 Nifedipine Extended Release Tablets Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NIFEDIPINE EXTENDED RELEASE TABLETS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nifedipine Extended Release Tablets Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nifedipine Extended Release Tablets Market
5.7 ESG Ratings of Leading Companies
6 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2025)
6.3 Global Nifedipine Extended Release Tablets Market Size by Type (2020-2025)
6.4 Global Nifedipine Extended Release Tablets Price by Type (2020-2025)
7 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nifedipine Extended Release Tablets Market Sales by Application (2020-2025)
7.3 Global Nifedipine Extended Release Tablets Market Size (M USD) by Application (2020-2025)
7.4 Global Nifedipine Extended Release Tablets Sales Growth Rate by Application (2020-2025)
8 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET SALES BY REGION
8.1 Global Nifedipine Extended Release Tablets Sales by Region
8.1.1 Global Nifedipine Extended Release Tablets Sales by Region
8.1.2 Global Nifedipine Extended Release Tablets Sales Market Share by Region
8.2 Global Nifedipine Extended Release Tablets Market Size by Region
8.2.1 Global Nifedipine Extended Release Tablets Market Size by Region
8.2.2 Global Nifedipine Extended Release Tablets Market Size by Region
8.3 North America
8.3.1 North America Nifedipine Extended Release Tablets Sales by Country
8.3.2 North America Nifedipine Extended Release Tablets Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nifedipine Extended Release Tablets Sales by Country
8.4.2 Europe Nifedipine Extended Release Tablets Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nifedipine Extended Release Tablets Sales by Region
8.5.2 Asia Pacific Nifedipine Extended Release Tablets Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nifedipine Extended Release Tablets Sales by Country
8.6.2 South America Nifedipine Extended Release Tablets Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nifedipine Extended Release Tablets Sales by Region
8.7.2 Middle East and Africa Nifedipine Extended Release Tablets Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET PRODUCTION BY REGION
9.1 Global Production of Nifedipine Extended Release Tablets by Region(2020-2025)
9.2 Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2025)
9.3 Global Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nifedipine Extended Release Tablets Production
9.4.1 North America Nifedipine Extended Release Tablets Production Growth Rate (2020-2025)
9.4.2 North America Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nifedipine Extended Release Tablets Production
9.5.1 Europe Nifedipine Extended Release Tablets Production Growth Rate (2020-2025)
9.5.2 Europe Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nifedipine Extended Release Tablets Production (2020-2025)
9.6.1 Japan Nifedipine Extended Release Tablets Production Growth Rate (2020-2025)
9.6.2 Japan Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nifedipine Extended Release Tablets Production (2020-2025)
9.7.1 China Nifedipine Extended Release Tablets Production Growth Rate (2020-2025)
9.7.2 China Nifedipine Extended Release Tablets Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Valeant Pharmaceuticals
10.1.1 Valeant Pharmaceuticals Basic Information
10.1.2 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Overview
10.1.3 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Market Performance
10.1.4 Valeant Pharmaceuticals Business Overview
10.1.5 Valeant Pharmaceuticals SWOT Analysis
10.1.6 Valeant Pharmaceuticals Recent Developments
10.2 Zydus Pharmaceuticals Inc
10.2.1 Zydus Pharmaceuticals Inc Basic Information
10.2.2 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Overview
10.2.3 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Market Performance
10.2.4 Zydus Pharmaceuticals Inc Business Overview
10.2.5 Zydus Pharmaceuticals Inc SWOT Analysis
10.2.6 Zydus Pharmaceuticals Inc Recent Developments
10.3 Aurobindo Pharma LTD
10.3.1 Aurobindo Pharma LTD Basic Information
10.3.2 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Overview
10.3.3 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Market Performance
10.3.4 Aurobindo Pharma LTD Business Overview
10.3.5 Aurobindo Pharma LTD SWOT Analysis
10.3.6 Aurobindo Pharma LTD Recent Developments
10.4 Pfizer Inc
10.4.1 Pfizer Inc Basic Information
10.4.2 Pfizer Inc Nifedipine Extended Release Tablets Product Overview
10.4.3 Pfizer Inc Nifedipine Extended Release Tablets Product Market Performance
10.4.4 Pfizer Inc Business Overview
10.4.5 Pfizer Inc Recent Developments
10.5 Sun Pharma Industries LTD
10.5.1 Sun Pharma Industries LTD Basic Information
10.5.2 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Overview
10.5.3 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Market Performance
10.5.4 Sun Pharma Industries LTD Business Overview
10.5.5 Sun Pharma Industries LTD Recent Developments
10.6 Osmotica Pharmaceuticals
10.6.1 Osmotica Pharmaceuticals Basic Information
10.6.2 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Overview
10.6.3 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Market Performance
10.6.4 Osmotica Pharmaceuticals Business Overview
10.6.5 Osmotica Pharmaceuticals Recent Developments
10.7 Alkem Laboratories Ltd.
10.7.1 Alkem Laboratories Ltd. Basic Information
10.7.2 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Overview
10.7.3 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Market Performance
10.7.4 Alkem Laboratories Ltd. Business Overview
10.7.5 Alkem Laboratories Ltd. Recent Developments
10.8 Novast Novast Laboratories, LTD
10.8.1 Novast Novast Laboratories, LTD Basic Information
10.8.2 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Overview
10.8.3 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Market Performance
10.8.4 Novast Novast Laboratories, LTD Business Overview
10.8.5 Novast Novast Laboratories, LTD Recent Developments
10.9 TWi Pharmaceuticals Inc.
10.9.1 TWi Pharmaceuticals Inc. Basic Information
10.9.2 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Overview
10.9.3 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Market Performance
10.9.4 TWi Pharmaceuticals Inc. Business Overview
10.9.5 TWi Pharmaceuticals Inc. Recent Developments
10.10 Shyndec Pharmaceutical Co., Ltd
10.10.1 Shyndec Pharmaceutical Co., Ltd Basic Information
10.10.2 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.10.3 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.10.4 Shyndec Pharmaceutical Co., Ltd Business Overview
10.10.5 Shyndec Pharmaceutical Co., Ltd Recent Developments
10.11 China National Pharmaceutical Industry Co., Ltd
10.11.1 China National Pharmaceutical Industry Co., Ltd Basic Information
10.11.2 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.11.3 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.11.4 China National Pharmaceutical Industry Co., Ltd Business Overview
10.11.5 China National Pharmaceutical Industry Co., Ltd Recent Developments
10.12 China Resource Pharmaceutical Group Co., Ltd
10.12.1 China Resource Pharmaceutical Group Co., Ltd Basic Information
10.12.2 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.12.3 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.12.4 China Resource Pharmaceutical Group Co., Ltd Business Overview
10.12.5 China Resource Pharmaceutical Group Co., Ltd Recent Developments
10.13 Anglikang Pharmaceutical Co., Ltd
10.13.1 Anglikang Pharmaceutical Co., Ltd Basic Information
10.13.2 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.13.3 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.13.4 Anglikang Pharmaceutical Co., Ltd Business Overview
10.13.5 Anglikang Pharmaceutical Co., Ltd Recent Developments
10.14 Warrant Chiral Pharmaceutical Co., Ltd
10.14.1 Warrant Chiral Pharmaceutical Co., Ltd Basic Information
10.14.2 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.14.3 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.14.4 Warrant Chiral Pharmaceutical Co., Ltd Business Overview
10.14.5 Warrant Chiral Pharmaceutical Co., Ltd Recent Developments
10.15 Tailison Pharmaceutical Co., Ltd
10.15.1 Tailison Pharmaceutical Co., Ltd Basic Information
10.15.2 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.15.3 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.15.4 Tailison Pharmaceutical Co., Ltd Business Overview
10.15.5 Tailison Pharmaceutical Co., Ltd Recent Developments
10.16 Baheal Medical Inc.
10.16.1 Baheal Medical Inc. Basic Information
10.16.2 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Overview
10.16.3 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Market Performance
10.16.4 Baheal Medical Inc. Business Overview
10.16.5 Baheal Medical Inc. Recent Developments
10.17 Bocheng Pharmaceutical Co., Ltd
10.17.1 Bocheng Pharmaceutical Co., Ltd Basic Information
10.17.2 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
10.17.3 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Market Performance
10.17.4 Bocheng Pharmaceutical Co., Ltd Business Overview
10.17.5 Bocheng Pharmaceutical Co., Ltd Recent Developments
11 NIFEDIPINE EXTENDED RELEASE TABLETS MARKET FORECAST BY REGION
11.1 Global Nifedipine Extended Release Tablets Market Size Forecast
11.2 Global Nifedipine Extended Release Tablets Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nifedipine Extended Release Tablets Market Size Forecast by Country
11.2.3 Asia Pacific Nifedipine Extended Release Tablets Market Size Forecast by Region
11.2.4 South America Nifedipine Extended Release Tablets Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nifedipine Extended Release Tablets by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nifedipine Extended Release Tablets Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nifedipine Extended Release Tablets by Type (2026-2035)
12.1.2 Global Nifedipine Extended Release Tablets Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nifedipine Extended Release Tablets by Type (2026-2035)
12.2 Global Nifedipine Extended Release Tablets Market Forecast by Application (2026-2035)
12.2.1 Global Nifedipine Extended Release Tablets Sales (K MT) Forecast by Application
12.2.2 Global Nifedipine Extended Release Tablets Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nifedipine Extended Release Tablets Market Size by Type (M USD)
Table 4. Global Nifedipine Extended Release Tablets Market Size by Application
Table 5. Nifedipine Extended Release Tablets Market Size Comparison by Region (M USD)
Table 6. Global Nifedipine Extended Release Tablets Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Nifedipine Extended Release Tablets Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nifedipine Extended Release Tablets Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine Extended Release Tablets as of 2025)
Table 11. Global Market Nifedipine Extended Release Tablets Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nifedipine Extended Release Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nifedipine Extended Release Tablets Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nifedipine Extended Release Tablets Sales by Type (K MT)
Table 27. Global Nifedipine Extended Release Tablets Market Size by Type (M USD)
Table 28. Global Nifedipine Extended Release Tablets Sales (K MT) by Type (2020-2025)
Table 29. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2025)
Table 30. Global Nifedipine Extended Release Tablets Market Size (M USD) by Type (2020-2025)
Table 31. Global Nifedipine Extended Release Tablets Market Share by Type (2020-2025)
Table 32. Global Nifedipine Extended Release Tablets Price (USD/KG) by Type (2020-2025)
Table 33. Global Nifedipine Extended Release Tablets Sales (K MT) by Application
Table 34. Global Nifedipine Extended Release Tablets Market Size by Application
Table 35. Global Nifedipine Extended Release Tablets Sales by Application (2020-2025) & (K MT)
Table 36. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2025)
Table 37. Global Nifedipine Extended Release Tablets Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nifedipine Extended Release Tablets Market Share by Application (2020-2025)
Table 39. Global Nifedipine Extended Release Tablets Sales Growth Rate by Application (2020-2025)
Table 40. Global Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K MT)
Table 41. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2025)
Table 42. Global Nifedipine Extended Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nifedipine Extended Release Tablets Market Size by Region (2020-2025)
Table 44. North America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K MT)
Table 45. North America Nifedipine Extended Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K MT)
Table 47. Europe Nifedipine Extended Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Nifedipine Extended Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K MT)
Table 51. South America Nifedipine Extended Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Nifedipine Extended Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nifedipine Extended Release Tablets Production (K MT) by Region(2020-2025)
Table 55. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2025)
Table 57. Global Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Valeant Pharmaceuticals Basic Information
Table 63. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Overview
Table 64. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Valeant Pharmaceuticals Business Overview
Table 66. Valeant Pharmaceuticals SWOT Analysis
Table 67. Valeant Pharmaceuticals Recent Developments
Table 68. Zydus Pharmaceuticals Inc Basic Information
Table 69. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Overview
Table 70. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Zydus Pharmaceuticals Inc Business Overview
Table 72. Zydus Pharmaceuticals Inc SWOT Analysis
Table 73. Zydus Pharmaceuticals Inc Recent Developments
Table 74. Aurobindo Pharma LTD Basic Information
Table 75. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Overview
Table 76. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Aurobindo Pharma LTD Business Overview
Table 78. Aurobindo Pharma LTD SWOT Analysis
Table 79. Aurobindo Pharma LTD Recent Developments
Table 80. Pfizer Inc Basic Information
Table 81. Pfizer Inc Nifedipine Extended Release Tablets Product Overview
Table 82. Pfizer Inc Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Inc Business Overview
Table 84. Pfizer Inc Recent Developments
Table 85. Sun Pharma Industries LTD Basic Information
Table 86. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Overview
Table 87. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sun Pharma Industries LTD Business Overview
Table 89. Sun Pharma Industries LTD Recent Developments
Table 90. Osmotica Pharmaceuticals Basic Information
Table 91. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Overview
Table 92. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Osmotica Pharmaceuticals Business Overview
Table 94. Osmotica Pharmaceuticals Recent Developments
Table 95. Alkem Laboratories Ltd. Basic Information
Table 96. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Overview
Table 97. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Alkem Laboratories Ltd. Business Overview
Table 99. Alkem Laboratories Ltd. Recent Developments
Table 100. Novast Novast Laboratories, LTD Basic Information
Table 101. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Overview
Table 102. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Novast Novast Laboratories, LTD Business Overview
Table 104. Novast Novast Laboratories, LTD Recent Developments
Table 105. TWi Pharmaceuticals Inc. Basic Information
Table 106. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Overview
Table 107. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. TWi Pharmaceuticals Inc. Business Overview
Table 109. TWi Pharmaceuticals Inc. Recent Developments
Table 110. Shyndec Pharmaceutical Co., Ltd Basic Information
Table 111. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 112. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Shyndec Pharmaceutical Co., Ltd Business Overview
Table 114. Shyndec Pharmaceutical Co., Ltd Recent Developments
Table 115. China National Pharmaceutical Industry Co., Ltd Basic Information
Table 116. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 117. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. China National Pharmaceutical Industry Co., Ltd Business Overview
Table 119. China National Pharmaceutical Industry Co., Ltd Recent Developments
Table 120. China Resource Pharmaceutical Group Co., Ltd Basic Information
Table 121. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 122. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. China Resource Pharmaceutical Group Co., Ltd Business Overview
Table 124. China Resource Pharmaceutical Group Co., Ltd Recent Developments
Table 125. Anglikang Pharmaceutical Co., Ltd Basic Information
Table 126. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 127. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Anglikang Pharmaceutical Co., Ltd Business Overview
Table 129. Anglikang Pharmaceutical Co., Ltd Recent Developments
Table 130. Warrant Chiral Pharmaceutical Co., Ltd Basic Information
Table 131. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 132. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Warrant Chiral Pharmaceutical Co., Ltd Business Overview
Table 134. Warrant Chiral Pharmaceutical Co., Ltd Recent Developments
Table 135. Tailison Pharmaceutical Co., Ltd Basic Information
Table 136. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 137. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Tailison Pharmaceutical Co., Ltd Business Overview
Table 139. Tailison Pharmaceutical Co., Ltd Recent Developments
Table 140. Baheal Medical Inc. Basic Information
Table 141. Baheal Medical Inc. Nifedipine Extended Release Tablets Product Overview
Table 142. Baheal Medical Inc. Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Baheal Medical Inc. Business Overview
Table 144. Baheal Medical Inc. Recent Developments
Table 145. Bocheng Pharmaceutical Co., Ltd Basic Information
Table 146. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 147. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Bocheng Pharmaceutical Co., Ltd Business Overview
Table 149. Bocheng Pharmaceutical Co., Ltd Recent Developments
Table 150. Global Nifedipine Extended Release Tablets Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Nifedipine Extended Release Tablets Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Nifedipine Extended Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Nifedipine Extended Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Nifedipine Extended Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Nifedipine Extended Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Nifedipine Extended Release Tablets Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Nifedipine Extended Release Tablets Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Nifedipine Extended Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Nifedipine Extended Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Nifedipine Extended Release Tablets Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Nifedipine Extended Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Nifedipine Extended Release Tablets Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Nifedipine Extended Release Tablets Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Nifedipine Extended Release Tablets Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Nifedipine Extended Release Tablets Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Nifedipine Extended Release Tablets Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nifedipine Extended Release Tablets Market Size by Type (M USD)
Table 4. Global Nifedipine Extended Release Tablets Market Size by Application
Table 5. Nifedipine Extended Release Tablets Market Size Comparison by Region (M USD)
Table 6. Global Nifedipine Extended Release Tablets Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Nifedipine Extended Release Tablets Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nifedipine Extended Release Tablets Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine Extended Release Tablets as of 2025)
Table 11. Global Market Nifedipine Extended Release Tablets Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nifedipine Extended Release Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nifedipine Extended Release Tablets Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nifedipine Extended Release Tablets Sales by Type (K MT)
Table 27. Global Nifedipine Extended Release Tablets Market Size by Type (M USD)
Table 28. Global Nifedipine Extended Release Tablets Sales (K MT) by Type (2020-2025)
Table 29. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2025)
Table 30. Global Nifedipine Extended Release Tablets Market Size (M USD) by Type (2020-2025)
Table 31. Global Nifedipine Extended Release Tablets Market Share by Type (2020-2025)
Table 32. Global Nifedipine Extended Release Tablets Price (USD/KG) by Type (2020-2025)
Table 33. Global Nifedipine Extended Release Tablets Sales (K MT) by Application
Table 34. Global Nifedipine Extended Release Tablets Market Size by Application
Table 35. Global Nifedipine Extended Release Tablets Sales by Application (2020-2025) & (K MT)
Table 36. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2025)
Table 37. Global Nifedipine Extended Release Tablets Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nifedipine Extended Release Tablets Market Share by Application (2020-2025)
Table 39. Global Nifedipine Extended Release Tablets Sales Growth Rate by Application (2020-2025)
Table 40. Global Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K MT)
Table 41. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2025)
Table 42. Global Nifedipine Extended Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nifedipine Extended Release Tablets Market Size by Region (2020-2025)
Table 44. North America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K MT)
Table 45. North America Nifedipine Extended Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K MT)
Table 47. Europe Nifedipine Extended Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Nifedipine Extended Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K MT)
Table 51. South America Nifedipine Extended Release Tablets Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Nifedipine Extended Release Tablets Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nifedipine Extended Release Tablets Production (K MT) by Region(2020-2025)
Table 55. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2025)
Table 57. Global Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Nifedipine Extended Release Tablets Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Valeant Pharmaceuticals Basic Information
Table 63. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Overview
Table 64. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Valeant Pharmaceuticals Business Overview
Table 66. Valeant Pharmaceuticals SWOT Analysis
Table 67. Valeant Pharmaceuticals Recent Developments
Table 68. Zydus Pharmaceuticals Inc Basic Information
Table 69. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Overview
Table 70. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Zydus Pharmaceuticals Inc Business Overview
Table 72. Zydus Pharmaceuticals Inc SWOT Analysis
Table 73. Zydus Pharmaceuticals Inc Recent Developments
Table 74. Aurobindo Pharma LTD Basic Information
Table 75. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Overview
Table 76. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Aurobindo Pharma LTD Business Overview
Table 78. Aurobindo Pharma LTD SWOT Analysis
Table 79. Aurobindo Pharma LTD Recent Developments
Table 80. Pfizer Inc Basic Information
Table 81. Pfizer Inc Nifedipine Extended Release Tablets Product Overview
Table 82. Pfizer Inc Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Inc Business Overview
Table 84. Pfizer Inc Recent Developments
Table 85. Sun Pharma Industries LTD Basic Information
Table 86. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Overview
Table 87. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sun Pharma Industries LTD Business Overview
Table 89. Sun Pharma Industries LTD Recent Developments
Table 90. Osmotica Pharmaceuticals Basic Information
Table 91. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Overview
Table 92. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Osmotica Pharmaceuticals Business Overview
Table 94. Osmotica Pharmaceuticals Recent Developments
Table 95. Alkem Laboratories Ltd. Basic Information
Table 96. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Overview
Table 97. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Alkem Laboratories Ltd. Business Overview
Table 99. Alkem Laboratories Ltd. Recent Developments
Table 100. Novast Novast Laboratories, LTD Basic Information
Table 101. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Overview
Table 102. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Novast Novast Laboratories, LTD Business Overview
Table 104. Novast Novast Laboratories, LTD Recent Developments
Table 105. TWi Pharmaceuticals Inc. Basic Information
Table 106. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Overview
Table 107. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. TWi Pharmaceuticals Inc. Business Overview
Table 109. TWi Pharmaceuticals Inc. Recent Developments
Table 110. Shyndec Pharmaceutical Co., Ltd Basic Information
Table 111. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 112. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Shyndec Pharmaceutical Co., Ltd Business Overview
Table 114. Shyndec Pharmaceutical Co., Ltd Recent Developments
Table 115. China National Pharmaceutical Industry Co., Ltd Basic Information
Table 116. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 117. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. China National Pharmaceutical Industry Co., Ltd Business Overview
Table 119. China National Pharmaceutical Industry Co., Ltd Recent Developments
Table 120. China Resource Pharmaceutical Group Co., Ltd Basic Information
Table 121. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 122. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. China Resource Pharmaceutical Group Co., Ltd Business Overview
Table 124. China Resource Pharmaceutical Group Co., Ltd Recent Developments
Table 125. Anglikang Pharmaceutical Co., Ltd Basic Information
Table 126. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 127. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Anglikang Pharmaceutical Co., Ltd Business Overview
Table 129. Anglikang Pharmaceutical Co., Ltd Recent Developments
Table 130. Warrant Chiral Pharmaceutical Co., Ltd Basic Information
Table 131. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 132. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Warrant Chiral Pharmaceutical Co., Ltd Business Overview
Table 134. Warrant Chiral Pharmaceutical Co., Ltd Recent Developments
Table 135. Tailison Pharmaceutical Co., Ltd Basic Information
Table 136. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 137. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Tailison Pharmaceutical Co., Ltd Business Overview
Table 139. Tailison Pharmaceutical Co., Ltd Recent Developments
Table 140. Baheal Medical Inc. Basic Information
Table 141. Baheal Medical Inc. Nifedipine Extended Release Tablets Product Overview
Table 142. Baheal Medical Inc. Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Baheal Medical Inc. Business Overview
Table 144. Baheal Medical Inc. Recent Developments
Table 145. Bocheng Pharmaceutical Co., Ltd Basic Information
Table 146. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Overview
Table 147. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Bocheng Pharmaceutical Co., Ltd Business Overview
Table 149. Bocheng Pharmaceutical Co., Ltd Recent Developments
Table 150. Global Nifedipine Extended Release Tablets Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Nifedipine Extended Release Tablets Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Nifedipine Extended Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Nifedipine Extended Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Nifedipine Extended Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Nifedipine Extended Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Nifedipine Extended Release Tablets Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Nifedipine Extended Release Tablets Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Nifedipine Extended Release Tablets Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Nifedipine Extended Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Nifedipine Extended Release Tablets Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Nifedipine Extended Release Tablets Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Nifedipine Extended Release Tablets Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Nifedipine Extended Release Tablets Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Nifedipine Extended Release Tablets Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Nifedipine Extended Release Tablets Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Nifedipine Extended Release Tablets Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nifedipine Extended Release Tablets
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nifedipine Extended Release Tablets Market Size (M USD), 2025-2035
Figure 5. Global Nifedipine Extended Release Tablets Market Size (M USD) (2020-2035)
Figure 6. Global Nifedipine Extended Release Tablets Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nifedipine Extended Release Tablets Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nifedipine Extended Release Tablets Product Life Cycle
Figure 13. Nifedipine Extended Release Tablets Sales Share by Manufacturers in 2025
Figure 14. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers in 2025
Figure 15. Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nifedipine Extended Release Tablets Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nifedipine Extended Release Tablets Revenue in 2025
Figure 18. Industry Chain Map of Nifedipine Extended Release Tablets
Figure 19. Global Nifedipine Extended Release Tablets Market PEST Analysis
Figure 20. Global Nifedipine Extended Release Tablets Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nifedipine Extended Release Tablets Market Share by Type
Figure 27. Sales Market Share of Nifedipine Extended Release Tablets by Type (2020-2025)
Figure 28. Sales Market Share of Nifedipine Extended Release Tablets by Type in 2025
Figure 29. Market Share of Nifedipine Extended Release Tablets by Type (2020-2025)
Figure 30. Market Share of Nifedipine Extended Release Tablets by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nifedipine Extended Release Tablets Market Share by Application
Figure 33. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2025)
Figure 34. Global Nifedipine Extended Release Tablets Sales Market Share by Application in 2025
Figure 35. Global Nifedipine Extended Release Tablets Market Share by Application (2020-2025)
Figure 36. Global Nifedipine Extended Release Tablets Market Share by Application in 2025
Figure 37. Global Nifedipine Extended Release Tablets Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2025)
Figure 39. Global Nifedipine Extended Release Tablets Market Size by Region (2020-2025)
Figure 40. North America Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nifedipine Extended Release Tablets Sales Market Share by Country in 2024
Figure 43. North America Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nifedipine Extended Release Tablets Market Size by Country in 2024
Figure 45. U.S. Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nifedipine Extended Release Tablets Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nifedipine Extended Release Tablets Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nifedipine Extended Release Tablets Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nifedipine Extended Release Tablets Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nifedipine Extended Release Tablets Sales Market Share by Country in 2024
Figure 53. Europe Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nifedipine Extended Release Tablets Market Size by Country in 2024
Figure 55. Germany Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nifedipine Extended Release Tablets Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nifedipine Extended Release Tablets Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nifedipine Extended Release Tablets Market Size by Region in 2024
Figure 68. China Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nifedipine Extended Release Tablets Sales and Growth Rate (K MT)
Figure 79. South America Nifedipine Extended Release Tablets Sales Market Share by Country in 2024
Figure 80. South America Nifedipine Extended Release Tablets Market Size and Growth Rate (M USD)
Figure 81. South America Nifedipine Extended Release Tablets Market Size by Country in 2024
Figure 82. Brazil Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nifedipine Extended Release Tablets Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nifedipine Extended Release Tablets Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nifedipine Extended Release Tablets Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nifedipine Extended Release Tablets Market Size by Region in 2024
Figure 92. Saudi Arabia Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nifedipine Extended Release Tablets Production Market Share by Region (2020-2025)
Figure 103. North America Nifedipine Extended Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nifedipine Extended Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nifedipine Extended Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nifedipine Extended Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nifedipine Extended Release Tablets Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Nifedipine Extended Release Tablets Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nifedipine Extended Release Tablets Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nifedipine Extended Release Tablets Market Share Forecast by Type (2026-2035)
Figure 111. Global Nifedipine Extended Release Tablets Sales Forecast by Application (2026-2035)
Figure 112. Global Nifedipine Extended Release Tablets Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Nifedipine Extended Release Tablets
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nifedipine Extended Release Tablets Market Size (M USD), 2025-2035
Figure 5. Global Nifedipine Extended Release Tablets Market Size (M USD) (2020-2035)
Figure 6. Global Nifedipine Extended Release Tablets Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nifedipine Extended Release Tablets Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nifedipine Extended Release Tablets Product Life Cycle
Figure 13. Nifedipine Extended Release Tablets Sales Share by Manufacturers in 2025
Figure 14. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers in 2025
Figure 15. Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nifedipine Extended Release Tablets Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nifedipine Extended Release Tablets Revenue in 2025
Figure 18. Industry Chain Map of Nifedipine Extended Release Tablets
Figure 19. Global Nifedipine Extended Release Tablets Market PEST Analysis
Figure 20. Global Nifedipine Extended Release Tablets Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nifedipine Extended Release Tablets Market Share by Type
Figure 27. Sales Market Share of Nifedipine Extended Release Tablets by Type (2020-2025)
Figure 28. Sales Market Share of Nifedipine Extended Release Tablets by Type in 2025
Figure 29. Market Share of Nifedipine Extended Release Tablets by Type (2020-2025)
Figure 30. Market Share of Nifedipine Extended Release Tablets by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nifedipine Extended Release Tablets Market Share by Application
Figure 33. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2025)
Figure 34. Global Nifedipine Extended Release Tablets Sales Market Share by Application in 2025
Figure 35. Global Nifedipine Extended Release Tablets Market Share by Application (2020-2025)
Figure 36. Global Nifedipine Extended Release Tablets Market Share by Application in 2025
Figure 37. Global Nifedipine Extended Release Tablets Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2025)
Figure 39. Global Nifedipine Extended Release Tablets Market Size by Region (2020-2025)
Figure 40. North America Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nifedipine Extended Release Tablets Sales Market Share by Country in 2024
Figure 43. North America Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nifedipine Extended Release Tablets Market Size by Country in 2024
Figure 45. U.S. Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nifedipine Extended Release Tablets Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nifedipine Extended Release Tablets Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nifedipine Extended Release Tablets Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nifedipine Extended Release Tablets Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nifedipine Extended Release Tablets Sales Market Share by Country in 2024
Figure 53. Europe Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nifedipine Extended Release Tablets Market Size by Country in 2024
Figure 55. Germany Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nifedipine Extended Release Tablets Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nifedipine Extended Release Tablets Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nifedipine Extended Release Tablets Market Size by Region in 2024
Figure 68. China Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nifedipine Extended Release Tablets Sales and Growth Rate (K MT)
Figure 79. South America Nifedipine Extended Release Tablets Sales Market Share by Country in 2024
Figure 80. South America Nifedipine Extended Release Tablets Market Size and Growth Rate (M USD)
Figure 81. South America Nifedipine Extended Release Tablets Market Size by Country in 2024
Figure 82. Brazil Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nifedipine Extended Release Tablets Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nifedipine Extended Release Tablets Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nifedipine Extended Release Tablets Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nifedipine Extended Release Tablets Market Size by Region in 2024
Figure 92. Saudi Arabia Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nifedipine Extended Release Tablets Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nifedipine Extended Release Tablets Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nifedipine Extended Release Tablets Production Market Share by Region (2020-2025)
Figure 103. North America Nifedipine Extended Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nifedipine Extended Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nifedipine Extended Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nifedipine Extended Release Tablets Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nifedipine Extended Release Tablets Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Nifedipine Extended Release Tablets Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nifedipine Extended Release Tablets Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nifedipine Extended Release Tablets Market Share Forecast by Type (2026-2035)
Figure 111. Global Nifedipine Extended Release Tablets Sales Forecast by Application (2026-2035)
Figure 112. Global Nifedipine Extended Release Tablets Market Share Forecast by Application (2026-2035)
